Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bristol-Myers Squibb

46.92
-0.0900-0.19%
Post-market: 47.050.1300+0.28%16:57 EDT
Volume:7.02M
Turnover:330.10M
Market Cap:95.49B
PE:17.57
High:47.27
Open:47.21
Low:46.70
Close:47.01
Loading ...

Bristol Myers Squibb Presents Late-Breaking Data From Pivotal Phase 3 Poetyk Psa-1 Trial Demonstrating Superiority of Sotyktu (Deucravacitinib) Compared With Placebo in Adults With Psoriatic Arthritis

THOMSON REUTERS
·
11 Jun

Bristol-Myers Squibb Co - Sotyktu Achieves Primary Endpoint With 54.2% Acr20 Response at Week 16

THOMSON REUTERS
·
11 Jun

Bristol-Myers Squibb Co - Sotyktu Demonstrates Consistent Safety Profile With No New Safety Signals

THOMSON REUTERS
·
11 Jun

Philochem AG Licenses OncoACP3 Rights to RayzeBio in $1.35bn Deal

Reuters
·
11 Jun

Xilio Therapeutics Appoints Dr. Akintunde Bello to Board of Directors, Enhancing Leadership in Cancer Immunotherapy Development

Reuters
·
11 Jun

Bristol Myers Squibb call volume above normal and directionally bullish

TIPRANKS
·
11 Jun

Bernstein Keeps Their Hold Rating on Bristol-Myers Squibb (BMY)

TIPRANKS
·
10 Jun

Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
10 Jun

Bristol-Myers Squibb: Hold Rating Amid Moderate Growth and Revenue Variability

TIPRANKS
·
09 Jun

3 Stocks With Mouthwatering Dividends You Can Buy Right Now

Motley Fool
·
08 Jun

Review -- Barron's

Dow Jones
·
07 Jun

Bristol-Myers Squibb’s Strategic Partnership with BioNTech: A Promising Future for BNT327 in Immunology Therapy

TIPRANKS
·
05 Jun

Bristol-Myers Squibb Files Initial Beneficial Ownership Statement for Wendy Short Bartie, EVP Corporate Affairs

Reuters
·
05 Jun

Trump's Tax Bill Is Testing the Dollar. This Red Flag Matters More. -- Barrons.com

Dow Jones
·
03 Jun

BioNTech Jumps Another 3.7% After Surging 18% as Bristol-Myers to Pay BioNTech Up to $11.1 Billion in Cancer Deal

Tiger Newspress
·
03 Jun

Post-Bell | U.S. Stocks Close Higher; Tesla Drops 1%; Nvidia Gains 2%; Cleveland-Cliffs Surges 23%; Applied Digital Soars 48%

Tiger Newspress
·
03 Jun

Sector Update: Health Care Stocks End Higher Late Afternoon

MT Newswires Live
·
03 Jun

HSBC Raises Bristol-Myers Squibb's Price Target to $50 From $47

MT Newswires Live
·
03 Jun

Bristol deal takes out ‘key’ potential buyer of Summit Therapeutics, says Truist

TIPRANKS
·
03 Jun

Bristol-Myers Squibb (BMY) Receives a Hold from Citi

TIPRANKS
·
03 Jun